**Research Highlights**

\(1\) Numbers of hair cells and auditory function in normal rats were observed after microinjection of lentivirus carrying enhanced green fluorescent protein and Atoh1 into the rat cochlea, and the production of new hair cells in cochlea was explored.

\(2\) Recombinant lentivirus carrying a reporter gene, enhanced green fluorescent protein, and the target gene Atoh1 were constructed by gene engineering methods. Then, recombinant lentivirus was injected into the cochlea of normal rats using a postauricular approach *via* the round window membrane. The results showed that recombinant lentivirus has no impact on the hair cell numbers and auditory functions, can infect hair and supporting cells, and promotes supporting cells to transdifferentiate into hair cells.

\(3\) Recombinant lentivirus carrying enhanced green fluorescent protein and the Atoh1 gene caused no obvious damage to cochlear hair cells or auditory function. The target gene carried in lentivirus was continuously expressed in the transfected cells, providing evidence for lentivirus research.

INTRODUCTION {#sec1-1}
============

In the mammalian embryonic period, cochlear hair cells and supporting cells have common precursor cells\[[@ref1]\]. Several genes control the differentiation of precursor cells and Atoh1 is an important one\[[@ref2]\]. Expression of Atoh1 can generate extra hair cells\[[@ref3][@ref4][@ref5]\], and many hair cell precursors die in Atoh1 null mice\[[@ref6]\]; thus, Atoh1 is probably necessary and sufficient to drive hair cell differentiation in the ear.

Lentivirus vector, based on the human immunodeficiency virus, can mediate stable *in vivo* gene transfer into differentiated neurons and infect dividing and nondividing cells\[[@ref7]\]. Lentivirus, as one of a number of retroviral vector systems, can integrate into the genomes of target cells\[[@ref7]\]. Based on these features, lentivirus vectors are potential vectors for transfer of genes to the inner ear, being safe and causing only minimal inflammatory reactions\[[@ref8]\]. Local cochlear injections of lentivirus do not enter the lungs, heart, femoral bone marrow, duodenum, contralateral ear\[[@ref8]\] or brain tissue\[[@ref9]\]. However, it is not clear whether local cochlear injection of lentivirus carrying Atoh1 would affect the auditory function and the number of hair cells, or induce generation of extra hair-like cells.

In this study, we aimed to observe the cochlear structure, hearing level and hair cell-like cells after microinjection of lentivirus carrying enhanced green fluorescent protein and Atoh1 into the cochlea of normal hearing rats *via* the cochlear round window by a postauricular approach.

RESULTS {#sec1-2}
=======

Quantitative analysis of experimental animals {#sec2-1}
---------------------------------------------

Forty adult Sprague-Dawley rats were randomly divided into four groups: a lentivirus-enhanced green fluorescent protein-Atoh1 microinjection group, a lentivirus-enhanced green fluorescent protein microinjection group, an artificial perilymph injection group and a non-injection group. Each group contained 10 rats. With the exception of the non-injection group, rats were injected respectively with lentivirus-enhanced green fluorescent protein-Atoh1, lentivirus-enhanced green fluorescent protein and artificial perilymph *via* the cochlear round window. No rats died, and all rats entered the final analysis.

General conditions of rats after injection {#sec2-2}
------------------------------------------

No rat had symptoms of wryneck, walking instability, paralysis, anorexia, or incision infection. There was no suppurative infection or tympanic membrane in the rat bony bulla.

Cochlear microinjection of recombinant lentivirus carrying extrinsic Atoh1 had no impact on rat hearing levels {#sec2-3}
--------------------------------------------------------------------------------------------------------------

The results of auditory brainstem response measurements revealed no significant differences in values among rats in the different groups before microinjection of lentivirus, and an insignificant difference after microinjection. The auditory brainstem response thresholds of rats in the same group did not differ significantly between before and after injection. The auditory brainstem response threshold valves are shown in [Figure 1](#F1){ref-type="fig"}.

![Effect of cochlear microinjection of recombinant lentivirus carrying extrinsic Atoh1 on rat hearing levels.\
The auditory brainstem response (ABR) threshold in the same rat was not different before and after injection. The ABR threshold in the same group also did not differ before and after injection. The ABR thresholds in all rats were recorded before injection and 30 days after injection.\
Data are expressed as mean ± SD. There are 10 rats in each group. Analysis of variance was used to compare ABR thresholds.\
LV: Lentivirus; EGFP: enhanced green fluorescent protein; dB SPL: decibel sound pressure level.](NRR-8-1551-g001){#F1}

Cochlear microinjection of recombinant lentivirus carrying extrinsic Atoh1 had no impact on the number of rat cochlear hair cells {#sec2-4}
---------------------------------------------------------------------------------------------------------------------------------

There were dispersive losses of inner or outer hair cells in all basal turns of cochlea ([Figure 2](#F2){ref-type="fig"}). Among all groups, neither the number of hair cells nor the survival rate in the basal, middle and apex turns differed significantly (Tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}).

![Effect of cochlear microinjection of recombinant lentivirus carrying extrinsic Atoh1 on rat cochlear hair cells (propidium iodide staining).\
Three rows of OHCs (OHC1, OHC2, OHC3) showed no differences. Arrows indicate dispersive loss of OHCs or IHCs. There was no significant difference in the numbers of hair cells among different groups. Scale bars: 2.5 μm.\
(A) Lentivirus-enhanced green fluorescent protein-Atoh1 microinjection group; (B) lentivirus-enhanced green fluorescent protein microinjection group; (C) artificial perilymph injection group; (D) non-injection group.\
OHC: Outer hair cell; IHC: inner hair cell.](NRR-8-1551-g002){#F2}

###### 

Effect of cochlear microinjection of recombinant lentivirus carrying extrinsic Atoh1 on the number of hair cells (/40-fold field; propidium iodide staining)

![](NRR-8-1551-g003)

###### 

Effect of cochlear microinjection of recombinant lentivirus carrying extrinsic Atoh1 on the survival rate of hair cells (%; propidium iodide staining)

![](NRR-8-1551-g004)

Cochlear microinjection of recombinant lentivirus carrying extrinsic Atoh1 promoted hair-like cell surface marker myosin 7a {#sec2-5}
---------------------------------------------------------------------------------------------------------------------------

When cochlear hair cells were transfected with lentivirus carrying enhanced green fluorescent protein-Atoh1, both enhanced green fluorescent protein and Atoh1 were expressed in rat cochlear hair cells as detected by immunochemical fluorescence staining.

In the lentivirus-enhanced green fluorescent protein-Atoh1 microinjection group, myosin 7a, which is a hair cell-related marker\[[@ref10]\], could be expressed in both cochlear hair cells and supporting cells. This finding provides evidence that supporting cells can be transfected by lentivirus carrying enhanced green fluorescent protein and Atoh1, then expressed myosin 7a. In the lentivirus-enhanced green fluorescent protein microinjection group and the artificial perilymph injection group, myosin 7a was only expressed in cochlear hair cells ([Figure 3](#F3){ref-type="fig"}).

![Effect of cochlear microinjection of recombinant lentivirus carrying extrinsic Atoh1 and enhanced green fluorescent protein (EGFP) on the cochlear central turn (immunochemical fluorescence staining).\
Expression of EGFP displayed green fluorescence. Expression of myosin 7a displaying red fluorescence. LV-EGFP could infect both cochlear hair cells and supporting cells (A, D). Long arrows represent hair cells and short arrows represent supporting cells. Scale bars: 2.5 μm.\
In the LV-EGFP-Atoh1 microinjection group: (A) The fluorescein isothiocyanate filter shows expression of EGFP. (B) The rhodamine filter shows expression of myosin 7a. (C) Merge of A and B.\
In the LV-EGFP microinjection group: (D) The fluorescein isothiocyanate filter shows expression of EGFP. (E) The rhodamine filter shows expression of myosin 7a. (F) Merge of D and E.\
In the artificial perilymph injection group: (G) Light microscopic view. (H) The rhodamine filter shows expression of myosin 7a. There were new hair-like cells formed in LV-EGFP-Atoh1 microinjection group, but no new hair-like cells in LV-EGFP microinjection group and artificial perilymph injection group.\
(I) PBS instead of myosin 7a antibody as a negative control.\
LV-EGFP: Lentivirus-enhanced green fluorescent protein.](NRR-8-1551-g005){#F3}

DISCUSSION {#sec1-3}
==========

Gene therapy is an important method for treating deafness caused by hair cell damage. Recently, lentivirus has been widely used as a gene carrier\[[@ref11][@ref12][@ref13]\], because it has a number of advantages. Lentivirus can infect dividing cells and nondividing cells (such as neural cells, hematopoietic stem cells, and hepatic cells), and the viral genome integrates into the host genome to enable long-term expression of target genes, with little immunogenicity and good biological safety\[[@ref14]\]. Studies have shown that lentivirus can be used as a carrier to express target genes\[[@ref15][@ref16]\]. We constructed a lentivirus based on human immunodeficiency virus and genetically exchanged the human immunodeficiency virus gp120 protein for G glycoproteins of the vesicular stomatitis virus, known as VSV-G, so that the lentivirus can target and infect cell types other than helper T-cells, which human immunodeficiency virus infects *via* binding of the gp120 protein to the CD4 receptor of helper T-cells.

At 30 days after injection, lentivirus successfully infected cochlear hair cells and supporting cells, and expressed green fluorescence. This finding indicates that lentivirus can infect the cochlea and express gene, as also reported by Pietola\[[@ref8]\].

Atoh1, which codes for a basic helix-loop-helix transcription factor, is one of a number of members of the basic helix-loop-helix family\[[@ref17]\]. Basic helix-loop-helix transcription factors control the development and differentiation of many systems in vertebrates\[[@ref18]\], including cochlear hair cells\[[@ref19]\]. Atoh1 (also known as math1) is essential for development of the peripheral and central nervous system\[[@ref20][@ref21][@ref22]\], and for the formation of some non-neural cell types\[[@ref23][@ref24]\]. Atoh1 plays a critical role in hair cell differentiation during development\[[@ref25][@ref26]\]. An Atoh1 conditional knockout mouse line shows progressive loss of almost all the inner hair cells and the majority of outer hair cells within 3 weeks of birth\[[@ref27]\]. In the neonatal and juvenile mouse, Atoh1 ectopic expression has converted partial cochlear Pillar and Deiters' cells to immature hair cells\[[@ref28]\]. In the postnatal mammalian cochlea, Atoh1 directs the formation of sensory mosaics and induces cell proliferation\[[@ref29]\]. We microinjected lentivirus carrying enhanced green fluorescent protein-Atoh1 into rat cochlea and found that myosin 7a, a hair cell-related marker\[[@ref10]\], was expressed in hair cells and supporting cells. However, myosin 7a was only expressed in hair cells when we microinjected lentivirus carrying enhanced green fluorescent protein or artificial perilymph into rat cochlea. This provides evidence that Atoh1 might transform some supporting cells into hair-like cells expressing myosin 7a in the normal adult rat cochlea. Kawamoto *et al*\[[@ref30]\] observed the auditory sensory epithelium and surrounding tissue using immunochemical fluorescence methods, and reported expression of myosin 7a in Corti's organ, interdental cells and Hensen cells, when Atoh1 carried by adenovirus was introduced into the cochlea of normal hearing guinea pigs. Izumikawa *et al*\[[@ref2]\] revealed that myosin 7a reappeared in hair cells damaged by ear drug toxicity after inoculation of Atoh1 carried by adenovirus into cochlea of deaf guinea pigs. These findings indicated that overexpression of Atoh1 may promote generation of hair-like cells in the cochlea and that this approach could be used to treat sensorineural deafness. However, further studies assessing whether hair-like cells express myosin 7a and have normal morphological and physiological functions of hair cells are needed.

Generally speaking, surgical methods for injecting vectors or cells into the animal cochlea include ventral\[[@ref31][@ref32]\] and postaural\[[@ref33]\] approaches. Damage to the trachea or large artery and vein branches during ventral approach surgery could induce animal death during or after surgery. However, relatively few important structures are exposed in postaural approach surgery. A postaural approach was adopted in our study. After cutting the posterior auricular sulcus skin and platysma muscle and pulling back the sternocleidomastoid muscle, we can expose the triangle region surrounded by the facial nerve and posterior belly of the digastrics muscle. When soft tissue and fascia overlapping the osseous tissue below the facial nerve and in front of the posterior belly of the digastrics muscle are separated, the bony bulla is exposed. The internal carotid artery is in the front of the bony bulla. Care should be taken to avoid damage to the internal carotid artery. The post-inferior region of the bony bulla is opened as a window, which is large enough to expose the stapedia artery and round window niche.

To detect an effect on auditory function caused by lentivirus microinjection, auditory brainstem response thresholds were measured before and after injection among the four groups. To avoid a probable influence of assessing different ears, the left ear was chosen for experiments. In the non-injection group, as in the normal control group, there was no significant difference in auditory brainstem response thresholds between before and after injection. In the artificial perilymph injection group, as in the surgery control group, there was also no significant difference. This provides evidence that surgery for injections did not affect the auditory functions of experimental animals. In the lentivirus-enhanced green fluorescent protein-Atoh1 microinjection group and the lentivirus-enhanced green fluorescent protein microinjection group, as experimental groups, no significant difference in auditory brainstem response thresholds was observed, indicating that the lentivirus had no impact on the auditory functions of experimental animals. Thus, lentivirus microinjection *via* the round window represents a potential method for treating inner ear diseases. It should be pointed out that different microinjection locations may have different influences on auditory functions. In our previous study, microinjection *via* the cochlear scala media lateral wall caused a higher auditory brainstem response threshold than was seen in non-injected rats\[[@ref34]\]. We think that injection *via* the cochlear lateral wall may damage the bony labyrinth or cause endolymph leakage. Microinjection *via* the round window can maximally reduce bony labyrinth structural damage and avoid perilymph leakage, which prevents any loss of hearing. However, there is some debate about whether auditory function is affected by microinjecting *via* the round window. Chen *et al*\[[@ref35]\] reported that auditory thresholds did not differ after microinjecting through an intact round window membrane in guinea pigs. However, Xu *et al*\[[@ref36]\] found that auditory function was severely damaged after microinjecting through an intact round window membrane in mouse, mainly due to rupture of the round window membrane.

To detect damage to hair cells caused by injection and lentivirus, we counted the numbers of hair cells among the four groups after injection. Our results demonstrated dispersive hair cell loss and no significant difference was seen among the four groups. Dispersive hair cell loss among the four groups may be caused during the preparation of the cochlear membrane. Under an optical microscope, cochlear structures showed no obvious damage after injection. This indicates that microinjection *via* the round window did not cause significant mechanical damage to hair cells or the cochlea. We speculate that the reasons for this are as follows: (1) injection slowly at a speed of 1 μL/min maximally avoids damage to cochlear structures and the degeneration of hair cells; (2) lentivirus might not change the microenvironment of the perilymph; (3) microinjection *via* the round window membrane and the subsequent fascia cover ensures inner ear integrity and avoids structural damage after injection. Consistent with this, Fu *et al*\[[@ref37]\] found no significant hair cell or stereocilia loss after neural stem cells were transplanted into the rat cochlea *via* the round window membrane.

Although we microinjected lentivirus carrying enhanced green fluorescent protein-Atoh1 and found that myosin 7a was expressed in supporting cells and hair cells, an urgent requirement is verification of whether the supporting cells expressing myosin 7a have the physiological properties of hair cells. Thus, the present study is only a preliminary study on the injection of lentivirus carrying Atoh1 into the cochlea *via* the round window. Extended observation periods and more detailed physiologic measures will be necessary to examine the long-term effects of this approach.

MATERIALS AND METHODS {#sec1-4}
=====================

Design {#sec2-6}
------

A randomized, controlled animal experiment.

Time and setting {#sec2-7}
----------------

The experiment was performed in the State Key Laboratory of Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital of Zhejiang University in China from October 2010 to November 2011.

Materials {#sec2-8}
---------

Forty Sprague-Dawley male rats, specific pathogen-free grade, weighing 150--200 g, were purchased from the Laboratory Animal Center of Zhejiang University in China (No. 2011-015) and fed at room temperature, under natural lighting and air with relative humidity about 50%. All experimental disposals were in accordance with the *Guidelines and Suggestions for the Care and Use of Laboratory Animals*, formulated by the Animal Care Committees of Zhejiang University, China.

Methods {#sec2-9}
-------

### Construction of recombinant lentivirus vectors {#sec3-1}

The recombinant lentivirus vectors were produced as previously described\[[@ref38]\]. Four plasmids were used to produce third-generation self-inactivating human immunodeficiency virus-1-based lentivirus vectors as follows: (1) the packaging constructs pMDIg-pRRE (Shanghai Televector Co., Ltd., Shanghai, China), in which the cytomegalovirus early promoter drove the synthesis of viral proteins including gag and pol; (2) the packaging constructs pRSV-REV (Shanghai Televector Co., Ltd.), which were rev cDNA expression plasmids, in which the joined second exons of human immunodeficiency virus-1 rev were under the transcriptional control of the rous sarcoma virus U3; (3) the plasmid pMD2G (Shanghai Televector Co., Ltd.), which produced the pseudotyping envelope vesicular stomatitis virus glycoprotein; and (4) the expression vector pLenti-enhanced green fluorescent protein-Neo (Shanghai Televector Co., Ltd.), in which the transgene was flanked by the human immunodeficiency virus-1 derived cis-acting sequences necessary for packaging, reverse transcription, and integration. Atoh1 cDNA, coding for the 1.056 kDa form of murine Atoh1 and bearing a site of *Sma*I and *Kpn*I on its 5′ and 3′ ends, was cloned by PCR from the template Atoh1 open reading frame sequence (FulenGen Co., Ltd., Guangzhou, Guangdong Province, China). Then, the Atoh1 cDNA was inserted into the unique *Sma*l and *Kpn*I sites of the pLenti-enhanced green fluorescent protein-Neo plasmid to acquire pLenti-enhanced green fluorescent protein-Atoh1 plasmid, which was controlled by the cytomegalovirus early promoter ([Figure 4](#F4){ref-type="fig"}).

![Structure of recombinant lentivirus.](NRR-8-1551-g006){#F4}

The PCR primers (Shanghai Sangon Biological Engineering Technology & Services Co., Ltd., Shanghai, China) were as follows: forward 5′-ATG TCC CGC CTG CTG CAT GC-3′ and reverse 5′-GGG GTA CCC TAA CTG GCC TCA TCA GAG TC-3′. Viral particles of lentivirus carrying enhanced green fluorescent protein-Atoh1 were produced by transiently cotransfecting the transfer plasmid pLenti- enhanced green fluorescent protein-Atoh1 (20 μg), the packaging plasmids pRev-REV (10 μg) and pMDIg- pRRE (15 μg), and the vesicular stomatitis virus glycoprotein envelope plasmid pMD2G (7.5 μg) into subconfluent 293T cells using the calcium chloride method. The medium was replaced 12 hours later and the culture supernatant containing viral particles were collected at 48 hours post-transfection and stored at −80°C. Viral titer was determined in Hela cells transduced with 10 and 100 times serial dilutions of concentrated viral supernatant and was found to be about 3 × 10^8^ TU/mL.

### Microinjection of recombinant lentivirus into cochlea {#sec3-2}

Rats were placed on a homothermal pad (37°C) after being anesthetized with ketamine (40 mg/kg) and chlorpromazine (20 mg/kg) intramuscularly. An incision was made along the post-helical sulcus after skin preparation and disinfection. The facial nerve and sternocleidomastoid muscle were well exposed after the skin was cut and the platysma was separated. We then separated the triangle surrounded by the facial nerve and sternocleidomastoid muscle deeply, so that the bony bulla could be exposed within the triangle surrounded by the facial nerve and digastric muscle ([Figure 5A](#F5){ref-type="fig"}). The stapedial artery and round window niche were exposed after a part of bulla bone was removed ([Figure 5B](#F5){ref-type="fig"}).

![Exposure of the cochlear round window for lentivirus injection. Scale bars: 25 μm.\
(A) When the skin is cut and the tissue is separated, the bony bulla is exposed.\
(B) When a part of the bulla bone is removed, the round window is exposed.](NRR-8-1551-g007){#F5}

A 20-μL microsyringe (Exmire Microsyringe; Ito Corporation, Fuji, Shizuoka, Japan), which was the same sort used in our previous study\[[@ref37]\], was inserted into the round window membrane. Then, 5 μL of lentivirus carrying enhanced green fluorescent protein-Atoh1, lentivirus carrying enhanced green fluorescent protein, or artificial perilymph (NaCl 125 mmol/L, KCl 3.5 mmol/L, MgCl~2~ 1.2 mmol/L, NaH~2~PO~4~ 0.75 mmol/L, NaHCO~3~ 25 mmol/L, glucose 5 mmol/L) was slowly microinjected into the scala tympani at the speed of 1 μL/min in the corresponding injection groups. The needle of the microsyringe was kept in the inner ear for 10 minutes to prevent backflow. A small piece of fascia was placed over the round window, and the incision was closed with sutures.

### Auditory brainstem response measurement for detecting hearing threshold variations {#sec3-3}

All animals were recorded for auditory brainstem response threshold before injection and 30 days after injection. Animals were intramuscularly anesthetized with ketamine (40 mg/kg) and chlorpromazine (20 mg/kg) before auditory brainstem response measurement. A Nicolet Compass system (Nicolet Diagnostics Ltd., San Carlos, CA, USA) was used at 10 ms duration, 11.1/s repetition rate, 150--2 000 Hz filtering band, and 1 000 times superposition, and the stimulation sound was a 0.1 ms broad band click. A recording electrode was inserted into the scalp in the middle position between the two ears. A reference electrode was inserted below the left ear and a ground electrode was inserted contralaterally. The threshold was defined as the lowest decibel sound pressure level (dB SPL) of stimulus at which a positive waveform in the evoked response tracing was evident and should be repeated\[[@ref39]\].

### Expression of myosin 7a in cochlear cells detected by immunochemical fluorescence staining {#sec3-4}

Ten anesthetized rats in three injection groups were sacrificed 30 days after injection. They were perfused intracardially with normal saline, followed by 4% paraformaldehyde in PBS. The left temporal bones were removed, then the cochlea were dissected and immersed in the same fixative at 4°C for 4 hours. After decalcification with 0.1 mol/L ethylene diamine tetraacetic acid for 7 days at 4°C, cochlea were incubated with 20% sucrose for 2 days and optimal cutting temperature compound for 1 hour before freezing. Cryostat sections (10 mm) of the cochlea were prepared. The sections were immersed in PBS for 10 minutes, then permeabilized with 0.3% Triton X-100 in PBS for 10 minutes. Non-specific binding of secondary antibody was blocked by incubation with 5% goat serum in PBS for 30 minutes. The sections were incubated overnight with mouse anti-rat enhanced green fluorescent protein monoclonal antibody (1:200; Beyotime Institute of Biotechnology, Haimen, Jiangsu Province, China), or rabbit anti-myosin7a polyclonal antibody (1:400; Santa Cruz Biotechnology, Santa Cruz, CA, USA) at 4°C using PBS as a negative control. After three PBS washes for 10 minutes each, the sections were incubated with secondary antibodies, rhodamine-conjugated goat anti-rabbit IgG (Santa Cruz Biotechnology; 1:400) or fluorescein- conjugated affinipure goat anti-mouse IgG (Jackson ImmunoResearch Newmarket, UK; 1:400), at room temperature for 1 hour. The sections were examined and photographed using a Leica DMRB epifluorescence microscope with a digital camera (Spot RT, Diagnostic Instrument or Polaroid DMC le, Sterling Heights, MI, USA).

### Assessing the numbers of cochlear hair cells using propidium iodide staining {#sec3-5}

At 30 days after injection, the numbers of hair cells were counted by the method of Ding *et al*\[[@ref40]\]. Five rats from each group were anesthetized and perfused intracardially with normal saline, followed by 4% paraformaldehyde in PBS. The left temporal bones were removed; then, the cochlea were dissected and immersed in the same fixative at 4°C for 4 hours. After cochlea was exposed, the spiral ligament, stria vascularis and tectorial membrane were removed. The basilar membranes were permeabilized with 0.3% Triton X-100 in PBS for 10 minutes and 0.5% propidium iodide in PBS for 20 minutes, then rinsed with PBS three times for 5 minutes each. The sections were mounted on slides containing 20% glycerol, then examined and photographed using a Leica DMRB epifluorescence microscope with a digital camera (Spot RT, Diagnostic Instrument or Polaroid DMC le). Whole basilar membranes were divided into three parts, consisting of the basal, center and apex turns.

### Statistical analysis {#sec3-6}

Data are expressed as mean ± SD and were statistically analyzed using SPSS 16.0 software (IBM Corporation, New York, NY, USA). Analysis of variance was used to compare values among groups. A value of *P* less than 0.05 was considered statistically significant.
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